Skip to main content
Clinical Trials/NL-OMON42271
NL-OMON42271
Completed
Not Applicable

The effects on bone metabolism in patients using hydroxychloroquine - HCQ and bone metabolism

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
81
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Patients with pSS, sarcoidosis, RA or SLE who start with HCQ

Exclusion Criteria

  • Other underlying auto\-immune disease
  • Use of medications against osteoporosis (e.g. bisphosphonates)
  • Severe vitamin D deficiency (serum level \< 20 nmol/L)
  • Untreated hyperthyroidism
  • Untreated hyperparathyroidism
  • Use of corticosteroids (prednisone equivalent of \> 7\.5 mg for \> 3 months in the last year)
  • Multiple myeloma
  • Mastocytosis

Outcomes

Primary Outcomes

Not specified

Similar Trials